Cargando…

A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy

BACKGROUND: Certain early-phase clinical trials have suggested that bone marrow-derived stem cell transplantation might improve left ventricular function in patients with non-ischaemic dilated cardiomyopathy (NIDCM), whereas others trials have revealed no benefit from this approach. We sought to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yi, Wang, Yiqin, Lin, Menglu, Zhou, Jiale, Wang, Zi, Jiang, Meng, He, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148892/ https://www.ncbi.nlm.nih.gov/pubmed/27938412 http://dx.doi.org/10.1186/s13287-016-0441-x

Ejemplares similares

The electrocardiogram in non-ischaemic-dilated cardiomyopathy
por: Crescenzi, Cinzia, et al.
Publicado: (2023)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Therapeutic Role of Mobilized Bone Marrow Cells in Children with Nonischemic Dilated Cardiomyopathy
por: Habeeb, Nevin M., et al.
Publicado: (2012)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Autologous Transplantation of Bone Marrow Adult Stem Cells for the Treatment of Idiopathic Dilated Cardiomyopathy
por: Westphal, Ricardo João, et al.
Publicado: (2014)

The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
por: Nelson, Tom, et al.
Publicado: (2019)

Defibrillator and non-ischaemic dilated cardiomyopathy: a never ending story
por: Notaristefano, Francesco, et al.
Publicado: (2019)

Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
por: Akhtar, M., et al.
Publicado: (2019)

New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
por: Pio Loco detto Gava, Carola, et al.
Publicado: (2023)

Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
por: Yang, Sirui, et al.
Publicado: (2013)

Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial
por: Hamshere, Stephen, et al.
Publicado: (2015)

Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy
por: Li, Mengbo, et al.
Publicado: (2020)

Clonal haematopoiesis of indeterminate potential‐related mutations and outcome in dilated and ischaemic cardiomyopathy
por: Wu, Jasmine M.F., et al.
Publicado: (2022)

Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role
por: Pezzato, Andrea, et al.
Publicado: (2023)

Combined evaluation of right ventricular function using echocardiography in non‐ischaemic dilated cardiomyopathy
por: Ishiwata, Jumpei, et al.
Publicado: (2021)

Serum autotaxin as a novel prognostic marker in patients with non‐ischaemic dilated cardiomyopathy
por: Araki, Takashi, et al.
Publicado: (2022)

Immunocompetent cells in durable ventricular assist device-implanted non-ischaemic dilated cardiomyopathy
por: Koga-Ikuta, Ayumi, et al.
Publicado: (2022)

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
por: Mirelis, Jesús G., et al.
Publicado: (2022)

Revascularisation for Ischaemic Cardiomyopathy
por: Li Kam Wa, Matthew E, et al.
Publicado: (2023)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Tilz, Roland R, et al.
Publicado: (2019)

High reproducibility of adenosine stress cardiac MR myocardial perfusion imaging in patients with non-ischaemic dilated cardiomyopathy
por: Lawson, Mark A, et al.
Publicado: (2014)

Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy
por: Ziff, Oliver J, et al.
Publicado: (2018)

Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue
por: Roselló-Lletí, Esther, et al.
Publicado: (2012)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Tilz, Roland R, et al.
Publicado: (2019)

Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014)

Myocardial reconstruction in ischaemic cardiomyopathy
por: Castelvecchio, Serenella, et al.
Publicado: (2019)

Differences in Clinical Presentation and Findings between Idiopathic Dilated and Ischaemic Cardiomyopathy in an Unselected Population of Heart Failure Patients
por: Mantziari, Lilian, et al.
Publicado: (2012)

Relationship between serum chloride and prognosis in non-ischaemic dilated cardiomyopathy: a large retrospective cohort study
por: Li, Xinyi, et al.
Publicado: (2022)

Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non‐ischaemic dilated cardiomyopathy: a meta‐analysis
por: Wang, Jie, et al.
Publicado: (2020)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis
por: Zhu, Tingfang, et al.
Publicado: (2022)

Serial Examination of an Inducible and Reversible Dilated Cardiomyopathy in Individual Adult Drosophila
por: Kim, Il-Man, et al.
Publicado: (2009)

Reply to: Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non‐ischaemic dilated cardiomyopathy: a meta‐analysis
por: Wang, Jie, et al.
Publicado: (2021)

A computational investigation into rate-dependant vectorcardiogram changes due to specific fibrosis patterns in non-ischæmic dilated cardiomyopathy
por: Gemmell, Philip M., et al.
Publicado: (2020)

Circulating microRNA‐29‐5p can add to the discrimination between dilated cardiomyopathy and ischaemic heart disease
por: Brundin, Martin, et al.
Publicado: (2021)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Left Atrial Geometry and Phasic Function Determined by Cardiac Magnetic Resonance Are Independent Predictors for Outcome in Non-Ischaemic Dilated Cardiomyopathy
por: Cojan-Minzat, Bianca Olivia, et al.
Publicado: (2021)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_t6417lavdkq1dsmr9gltkfau6p